Seizures in Alzheimer disease: Who, when, and how common?

Archives of Neurology

Volumn 66, Issue 8, 2009, Pages 992-997

  Scarmeas, Nikolaos ^a,b   Honig, Lawrence S ^a,b   Choi, Hyunmi ^b   Cantero, Julio ^b,f   Brandt, Jason ^c   Blacker, Deborah ^d   Albert, Marilyn ^c   Amatniek, Joan C ^e   Marder, Karen ^a,b   Bell, Karen ^a,b   Hauser, W Allen ^a,b   Stern, Yaakov ^a,b  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^f FLORIDA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLINESTERASE INHIBITOR; NEUROLEPTIC AGENT;

ACADEMIC ACHIEVEMENT; ADULT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; CHECKLIST; COGNITION; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; DISEASE PREDISPOSITION; ELECTROENCEPHALOGRAM; EPILEPSY; ETHNICITY; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; IDIOPATHIC DISEASE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; RACE; RISK ASSESSMENT; RISK FACTOR; SEIZURE; SURVIVAL;

ACADEMIC MEDICAL CENTERS; AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATTENTION; COHORT STUDIES; COMORBIDITY; CONFUSION; CROSS-SECTIONAL STUDIES; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEIZURES; SYNCOPE; UNITED STATES;

EID: 68549089091     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2009.130     Document Type: Article

References (36)

1. Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA. Dementia and adult-onset unprovoked seizures. Neurology. 1996;46(3):727-730.
2. Hauser WA, Morris ML, Heston LL, Anderson VE. Seizures and myoclonus in patients with Alzheimer's disease. Neurology. 1986;36(9):1226-1230.
3. Romanelli MF, Morris JC, Ashkin K, Coben LA. Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch Neurol. 1990;47(8):847-850.
4. Amatniek JC, Hauser WA, DelCastillo-Castaneda C, et al. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia. 2006;47(5): 867-872.
5. Palop JJ, Chin J, Roberson ED, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron. 2007;55(5):697-711.
6. Sulkava R. Alzheimer's disease and senile dementia of Alzheimer type: a comparative study. Acta Neurol Scand. 1982;65(6):636-650.
7. Volicer L, Smith S, Volicer BJ. Effect of seizures on progression of dementia of the Alzheimer type. Dementia. 1995;6(5):258-263.
8. Mendez MF, Catanzaro P, Doss RC, Arguello R, Frey WH II. Seizures in Alzheimer's disease: clinicopathologic study. J Geriatr Psychiatry Neurol. 1994;7 (4):230-233.
9. Sjögren H. Clinical analysis of morbus Alzheimer and morbus Pick. Acta Psychiatr Scand. 1952;82(suppl):67-115. doi:10.1111/j.1600-0447. 1952.tb10980.x.
10. Risse SC, Lampe TH, Bird TD, et al. Myoclonus, seizures, and paratonia in Alzheimer disease. Alzheimer Dis Assoc Disord. 1990;4(4):217-225.
11. Seltzer B, Sherwin I. A comparison of clinical features in early- and late-onset primary degenerative dementia: one entity or two? Arch Neurol. 1983;40(3): 143-146.
12. Heyman A, Wilkinson WE, Hurwitz BJ, et al. Early-onset Alzheimer's disease: clinical predictors of institutionalization and death. Neurology. 1987;37(6):980-984.
13. Samson WN, van Duijn CM, Hop WC, Hofman A. Clinical features and mortality in patients with early-onset Alzheimer's disease. Eur Neurol. 1996;36(2):103-106.
14. Scarmeas N, Hadjigeorgiou GM, Papadimitriou A, et al. Motor signs during the course of Alzheimer disease. Neurology. 2004;63(6):975-982.
15. Scarmeas N, Albert M, Brandt J, et al. Motor signs predict poor outcomes in Alzheimer disease. Neurology. 2005;64(10):1696-1703.
16. Scarmeas N, Brandt J, Albert M, et al. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol. 2005;62(10):1601-1608.
17. Stern Y, Folstein M, Albert M, et al. Multicenter study of predictors of disease course in Alzheimer disease (the "Predictors Study"), I: study design, cohort description, and intersite comparisons. Alzheimer Dis Assoc Disord. 1993;7(1):3-21.
18. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-198.
19. Stern Y, Sano M, Paulson J, Mayeux R. Modified Mini-Mental State Examination: validity and reliability [abstract]. Neurology. 1987;37(suppl 1):179.
20. Mayeux R, Stern Y, Rosen J, Leventhal J. Depression, intellectual impairment, and Parkinson disease. Neurology. 1981;31(6):645-650.
21. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114(512):797-811.
22. Devanand DP, Miller L, Richards M, et al. The Columbia University Scale for Psychopathology in Alzheimer's Disease. Arch Neurol. 1992;49(4):371-376.
23. Holtzer R, Scarmeas N, Wegesin DJ, et al. Depressive symptoms in Alzheimer's disease: natural course and temporal relation to function and cognitive status. J Am Geriatr Soc. 2005;53(12):2083-2089.
24. Scarmeas N, Brandt J, Blacker D, et al. Disruptive behavior as a predictor in Alzheimer disease. Arch Neurol. 2007;64(12):1755-1761.
25. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
26. Hixson JE; Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Arterioscler Thromb. 1991;11(5):1237-1244.
27. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 1993;34(3):453-468.
28. Hauser WA, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc. 1996;71(6):576-586.
29. Lawless J. Statistical Model and Methods for Lifetime Data. New York, NY: John Wiley & Sons Inc; 1982.
30. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174.
31. Jacobs D, Sano M, Marder K, et al. Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology. 1994;44 (7):1215-1220.
32. Krumholz A, Wiebe S, Gronseth G, et al; Quality Standards Subcommittee of the American Academy of Neurology; American Epilepsy Society. Practice parameter: evaluating an apparent unprovoked first seizure in adults (an evidencebased review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2007; 69(21):1996-2007.
33. Corey LA, Kjeldsen MJ, Solaas MH, Nakken KO, Friis ML, Pellock JM. The accuracy of self-reported history of seizures in Danish, Norwegian and U.S. twins. Epilepsy Res. 2009;84(1):1-5.
34. Mayeux R, Stern Y, Spanton S. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology. 1985;35(4):453-461.
35. Scarmeas N, Anderson KE, Hilton J, et al. APOE-dependent PET patterns of brain activation in Alzheimer disease. Neurology. 2004;63(5):913-915.
36. Scarmeas N, Brandt J, Albert M, et al. Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology. 2002; 58(8):1182-1188.